Richie Eu

Richie EU was appointed Managing Director of Eu Yan Sang Ventures (“EYSV”) as of January 2026 with a focus on building and leading new brands for the Group. This includes a new venture to reimagine Traditional Chinese Medicine in a modern format, alongside EYSI’s new shareholders Mitsui & Co. (“Mitsui”), Rohto Pharmaceuticals (“Rohto”) and The Mentholatum Company (“TMC”).

Prior to this, he led Mergers & Acquisitions at Eu Yan Sang International Pte. Ltd. (“EYS”) and led the acquisition of Singapore-based postnatal brand Madam Partum and clinic group Chien Chi Tow in 2023, enhancing EYS’ service offering in women’s health.

From 2017 – 2020, he was the Managing Director of Eu Yan Sang Trading (Hong Kong) and oversaw retail, wholesale, and eCommerce operations across Hong Kong and Macau which included the launch of several products that have now formed an important of the EYS group portfolio.

He is also a Board Member of talenTtrust, a skills-based volunteering organization that pairs charities with mentors from professional backgrounds and Rainbow Centre, providing education for children with special needs over 3 campuses in Singapore.

He holds a Bachelor of Science degree in Business Administration from Babson College in Wellesley (Massachusetts) and represents the fifth generation at EYS.